Cargando…

Regulating for Bias in Medical Education – Reaction to the Pharmaceutical Industry Updated EFPIA Code of Practice

The European Federation of Pharmaceutical Industries and Associations (EFPIA) representing the pharmaceutical industry operating in Europe, introduced three codes of conduct between 2007 and 2013, which had a common goal of self-regulating interactions with healthcare professionals and patient organ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodzinka, Marcin, Seebohm, Annabel, Pozniak, Eugene, Mosch, Lina, De Luca, Lara, McArdle, Jill, Griebenow, Reinhard, Velcheva, Margarita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2019
Materias:	Position Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882466/ https://www.ncbi.nlm.nih.gov/pubmed/31807368 http://dx.doi.org/10.1080/21614083.2019.1685771

Ejemplares similares

Proposed changes to the reimbursement of pharmaceuticals and medical devices in Poland and their impact on market access and the pharmaceutical industry
por: Badora, Karolina, et al.
Publicado: (2017)

The future of accreditation of continuing medical education (CME)-continuing professional development (CPD) in Europe: harmonisation through dialogue and consensus
por: de Andrade, Fabiola, et al.
Publicado: (2018)

Position paper on current aspects of sponsoring in accredited CME
por: Stolz, Daiana, et al.
Publicado: (2017)

Outcomes in CME/CPD - Special Collection: How to make the “pyramid” a perpetuum mobile
por: Griebenow, Reinhard, et al.
Publicado: (2020)

Standards for Substantive Equivalency between Continuing Professional Development/Continuing Medical Education (CPD/CME) Accreditation Systems
por: Regnier, Kate, et al.
Publicado: (2021)

Effective Pharmacovigilance System Development: EFPIA-IPVG Consensus Recommendations
por: Peters, Tanja, et al.
Publicado: (2020)

Moving towards less biased research
por: Yarborough, Mark
Publicado: (2021)

Framework for industry engagement and quality principles for industry-provided medical education in Europe
por: Allen, Tamara, et al.
Publicado: (2017)

Pharmaceutical pricing, cost containment and new treatments for rare diseases in children
por: Stella, Peter, et al.
Publicado: (2014)

Osteoporosis in the European Union: medical management, epidemiology and economic burden: A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA)
por: Hernlund, E., et al.
Publicado: (2013)

Social pharmaceutical innovation and alternative forms of research, development and deployment for drugs for rare diseases
por: Douglas, Conor M. W., et al.
Publicado: (2022)

EFPIA Guideline on a Quality Framework of Principles in Lifelong Learning in Healthcare
por: Hofstädter-Thalmann, Eva, et al.
Publicado: (2022)

Transparency or restricting gifts? Polish medical students’ opinions about regulating relationships with pharmaceutical sales representatives
por: Makowska, Marta, et al.
Publicado: (2021)

Position statement on the role of healthcare professionals, patient organizations and industry in European Reference Networks
por: Hollak, Carla E. M., et al.
Publicado: (2016)

Together4RD position statement on collaboration between European reference networks and industry
por: Hedley, Victoria, et al.
Publicado: (2023)

Industry - from sponsor to provider?
por: Griebenow, Reinhard
Publicado: (2017)

Position Statement from the German Biobank Alliance on the Cooperation Between Academic Biobanks and Industry Partners
por: Baber, Ronny, et al.
Publicado: (2019)

International consortium for innovation and quality: An industry perspective on the nonclinical and early clinical development of intravitreal drugs
por: Pruimboom‐Brees, Ingrid M., et al.
Publicado: (2023)

Disease modifying treatment trials in Parkinson’s disease: how to balance expectations and interests of patients, physicians and industry partners?
por: Berg, D., et al.
Publicado: (2020)

European region of the WCPT statement on physiotherapy in primary care
por: Long, Jill
Publicado: (2019)

Independent Continuing Medical Education (CME)/Continuing Professional Development (CPD) Must Deliver Unbiased Information
por: Guenova, Margarita, et al.
Publicado: (2019)

Primary lymphedema French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins)
por: Vignes, Stéphane, et al.
Publicado: (2021)

Dynamic Regulatory Assessment: evolving the European Regulatory Framework for the Benefit of Patients and Public Health—an EFPIA View
por: Herrero-Martinez, Esteban, et al.
Publicado: (2022)

The SMA Clinical Trial Readiness Program: creation and evaluation of a program to enhance SMA trial readiness in the United States
por: Peterson, Ilse, et al.
Publicado: (2020)

The Role of Modeling and Simulation in Development and Registration of Medicinal Products: Output From the EFPIA/EMA Modeling and Simulation Workshop
por: Manolis, E, et al.
Publicado: (2013)

Nonclinical Studies that Support Viral Vector-Delivered Gene Therapies: An EFPIA Gene Therapy Working Group Perspective
por: Bolt, Michael W., et al.
Publicado: (2020)

Management of dyslipidemia in Poland: Interdisciplinary Expert Position Statement endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy. The Fourth Declaration of Sopot
por: Szymański, Filip M., et al.
Publicado: (2022)

Academic College of Emergency Experts in India's INDO-US Joint Working Group and OPUS12 Foundation Consensus Statement on Creating A Coordinated, Multi-Disciplinary, Patient-Centered, Global Point-of-Care Biomarker Discovery Network
por: Stawicki, Stanislaw P., et al.
Publicado: (2014)

Expert opinion on the creating and operating of the regional Pulmonary Embolism Response Teams (PERT). Polish PERT Initiative
por: Araszkiewicz, Aleksander, et al.
Publicado: (2020)

Italian guidelines for the treatment of type 2 diabetes
por: Mannucci, Edoardo, et al.
Publicado: (2022)

2023 update on Italian guidelines for the treatment of type 2 diabetes
por: Mannucci, Edoardo, et al.
Publicado: (2023)

Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), and the International Osteoporosis Foundation (IOF) under the auspices of WHO Collaborating Center for Epidemiology of Musculoskeletal Health and Aging
por: Shevroja, Enisa, et al.
Publicado: (2023)

UK clinical guideline for the prevention and treatment of osteoporosis
por: Gregson, Celia L., et al.
Publicado: (2022)

Diagnosis and management of individuals with Fetal Valproate Spectrum Disorder; a consensus statement from the European Reference Network for Congenital Malformations and Intellectual Disability
por: Clayton-Smith, Jill, et al.
Publicado: (2019)

International society of sports nutrition position stand: tactical athlete nutrition
por: Gonzalez, Drew E., et al.
Publicado: (2022)

Clinical Oncology Society of Australia: Position statement on cancer‐related malnutrition and sarcopenia
por: Kiss, Nicole, et al.
Publicado: (2020)

Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
por: Moon, Rebecca J., et al.
Publicado: (2023)

Local therapy of cancer with free IL-2
por: Den Otter, Willem, et al.
Publicado: (2008)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women
por: Kanis, J. A., et al.
Publicado: (2008)

Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond
por: Britten, C. M., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_esv0icicsclmllh8oeprgm3e07